| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/11/2006 | CN1720234A Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives |
| 01/11/2006 | CN1720233A Pesticidal sulphonylaminopyrazoles |
| 01/11/2006 | CN1720225A N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| 01/11/2006 | CN1720224A Vasculostatic agents and methods of use thereof |
| 01/11/2006 | CN1720043A Non-nucleoside reverse transcriptase inhibitors |
| 01/11/2006 | CN1718577A Medicinal composition containing alkyl acyl ramosqiong and its application |
| 01/10/2006 | US6984735 Reacting a dihalaromatic compound with sulfoxide |
| 01/10/2006 | US6984651 Piperidine amides as modulators of chemokine receptor activity |
| 01/10/2006 | US6984642 for treating cardiovascular disorders, for example for the acute and chronic treatment of ischaemic disorders |
| 01/10/2006 | US6984639 such as (2S)-3,3-dimethyl-1-[2-(5-phenylpentanoyl) pyrrolidinyl]pentane-1,2-dione which has affinity for immunophilin; for treatment of neurological disorders/neurodegenerative diseases; nerve growth factors; FK binding proteins |
| 01/10/2006 | CA2223918C Pyrrole derivatives and medicinal composition |
| 01/10/2006 | CA2129990C Benzodiazepin derivatives useful as cck-receptor antagonists |
| 01/10/2006 | CA2129897C Coa-it and paf inhibitors |
| 01/05/2006 | WO2006002434A2 Novel indazole carboxamides and their use |
| 01/05/2006 | WO2006001866A2 Crystalline forms of n-desmethylclozapine |
| 01/05/2006 | WO2006000759A1 Substituted diketopiperazines as oxytocin antagonists |
| 01/05/2006 | WO2006000400A1 Substituted diketopiperazines as oxytocin antagonists |
| 01/05/2006 | WO2005099709A3 Bicyclic heterocycles useful as serine protease inhibitors |
| 01/05/2006 | WO2005085194A3 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors |
| 01/05/2006 | WO2005035505A3 Compounds with phosphodiesterase inhibiting and calcium channel blocking activities |
| 01/05/2006 | WO2004080976A8 Phthalazinone derivatives |
| 01/05/2006 | US20060004207 Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods |
| 01/05/2006 | US20060004198 Method for producing substituted phenylsulfonyl urea |
| 01/05/2006 | US20060004195 Alpha,beta-unsaturated esters and acids by stereoselective dehydration |
| 01/05/2006 | US20060004188 Chemically reactive carbocyanine dyes incorporating an indolium ring moiety that is substituted at the 3-position by a reactive group or by a conjugated substance |
| 01/05/2006 | US20060004081 Cytotoxic compounds and conjugates |
| 01/05/2006 | US20060004075 Substituted aryl amides as IP antagonists |
| 01/05/2006 | US20060004069 Agent for preventing or treating neuropathy |
| 01/05/2006 | US20060004059 Substituted heterocycles for the treatment of diabetes and other diseases |
| 01/05/2006 | US20060004044 3-glyoxylamideindoles for treating cancer |
| 01/05/2006 | US20060004043 Indazole compounds and methods of use thereof |
| 01/05/2006 | US20060004033 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 01/05/2006 | US20060004030 Asthma, antiallergens; rheumatoid arthritis and atherosclerosis; anticarcinogenic agents; 2-(Benzylthio)-6-{[(1R)-2-hydroxy-1-methylethyl]amino}-4-pyrimidinol |
| 01/05/2006 | US20060004029 Nitrogen-containing aromatic derivatives |
| 01/05/2006 | US20060004021 Ethyl 4-{[2-(3-chlorophenyl)-2H-tetrazol-5-yl]methyl}piperazine-1-carboxylate; gastrointestinal disorders, chronic and acute pain, psychiatric and neurological disorders; obesity |
| 01/05/2006 | US20060004020 Pyrrolidine derivatives as oxytocin antagonists |
| 01/05/2006 | US20060004017 Quinazoline derivatives as angiogenesis inhibitors |
| 01/05/2006 | US20060004013 Cinnamide compound |
| 01/05/2006 | US20060004005 Triazines derivatives as cell adhesion inhibitors |
| 01/05/2006 | US20060004000 N-aryl-5-substituted-3-yl-1H-indazole-3-carboxamides; amidation of the 1-protected-1H-indazole-3-carboxylic acid, deblocking; hypotensive agents |
| 01/05/2006 | US20060003994 Pyrrolo[2,1-c][1,4]benzodiazepine-napthalimide conjugates linked through piperazine moiety and process for preparation thereof |
| 01/05/2006 | US20060003993 Benzotriazepnes as gastrin and cholecystokinin receptor ligands |
| 01/05/2006 | DE69828607T2 CHINOLIN- UND CHINOXALIN-VERBINDUNGEN DIE DEN VON BLUTPLÄTTCHEN ABSTAMMMENDEN WACHSTUMSFAKTOR UND/ODER PDGF- UND P56lck-TYROSIN-KINASE HEMMEN Quinoline and quinoxaline THE COMPOUNDS OF THE PLATELET FACTOR ABSTAMMMENDEN GROWTH AND / OR PDGF-TYROSINE KINASE AND p56 HEMMEN |
| 01/05/2006 | DE102004027821A1 Benzimidazole, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel Benzimidazoles, process for their preparation and their use as medicaments |
| 01/05/2006 | CA2571529A1 Substituted diketopiperazines as oxytocin antagonists |
| 01/05/2006 | CA2571436A1 Triazinyl-flavonate brighteners |
| 01/05/2006 | CA2570873A1 Pyrimidine urea derivatives as kinase inhibitors |
| 01/05/2006 | CA2570673A1 Compounds and methods for treating dyslipidemia |
| 01/05/2006 | CA2570615A1 Drugs for treating duplication of hypertension with hyperuricemia and /or hypercholesterolemia |
| 01/04/2006 | EP1611891A2 Use of (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 01/04/2006 | EP1611125A1 Heteroaryl substituted pyrolls useful as inhibitors of protein kinases |
| 01/04/2006 | EP1611122A1 Substituted pyrazole compounds |
| 01/04/2006 | EP1611121A1 Pyridazinone derivatives as cdk2-inhibitors |
| 01/04/2006 | EP1611108A1 Method for the production of telmisartan |
| 01/04/2006 | EP1611107A1 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders |
| 01/04/2006 | EP1611096A2 Benzamide modulators of metabotropic glutamate receptors |
| 01/04/2006 | EP1611094A1 Pyrazole compounds |
| 01/04/2006 | EP1611091A1 Novel compounds |
| 01/04/2006 | EP1610812A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 01/04/2006 | EP1610753A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 01/04/2006 | EP1409455B1 Prostaglandin analogues-as ep4 receptor agonists |
| 01/04/2006 | EP1319047B1 Cyanine dyes |
| 01/04/2006 | EP1147088B1 6-arylphenanthridines with pde-iv inhibiting activity |
| 01/04/2006 | CN1717404A 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 01/04/2006 | CN1717401A Anilinopyrazole derivatives useful for the treatment of diabetes |
| 01/04/2006 | CN1717396A Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 01/04/2006 | CN1717250A Anti-cancer and anti-infectious disease compositions and methods for using same |
| 01/04/2006 | CN1717175A Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides |
| 01/04/2006 | CN1715278A Process for preparing candesartan cilexetil C-form crystal |
| 01/04/2006 | CN1234694C New imidazoline compound, its preparation method and drug composition containing them |
| 01/04/2006 | CN1234693C Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 01/03/2006 | US6982332 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering CNS activity |
| 01/03/2006 | US6982330 Tricarbazolotriazines |
| 01/03/2006 | US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
| 01/03/2006 | US6982268 Useful in the treatment of a variety of central nervous system disorders in humans including anxiety, depression, sleep disorders, attention deficit disorder, or Alzheimer's dementia |
| 01/03/2006 | US6982267 For therapy of metabolic and eating disorders such as obesity and hyperphagia, and therapy of diabetes |
| 01/03/2006 | US6982266 N-(4-indol-5-yloxyphenyl){4-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]piperazinyl}carboxamide for example; antiproliferative agents which inhibit phosphorylation of kinases such as tyrosine kinase; cancer, arteriosclerosis |
| 01/03/2006 | US6982264 Enzyme inhibitors of beta-secretase-mediated cleavage of amyloid precuror proteins; congnition activators; Down's syndrome; Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-type; Parkinson's disease; hemostatic agents |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | US6982261 A progesterone receptor antagonist for providing progestational therapy, treating cancer of breast, uterine, ovarian, endometrial, or prostate, providing contraceptives, hormone replacement therapy |
| 01/03/2006 | US6982260 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 01/03/2006 | US6982259 N-heterocyclic derivatives as NOS inhibitors |
| 01/03/2006 | CA2187449C Anti-cancer compounds containing cyclopentaquinazoline ring |
| 01/03/2006 | CA2162463C Azolylamine derivative |
| 12/29/2005 | WO2005123723A1 3-cycloalkylbenzazepines as histamine h3 antagonists |
| 12/29/2005 | WO2005123722A1 Heterocyclic carboxamides with microbiocidal activity |
| 12/29/2005 | WO2005123721A2 Amorphous and polymorphic forms of candesartan cilexetil |
| 12/29/2005 | WO2005123720A1 Fine particles of the angiotensin ii antagonist candesartan cilexetil and process for production thereof |
| 12/29/2005 | WO2005123719A1 Compounds and compositions as protein kinase inhibitors |
| 12/29/2005 | WO2005123718A2 Benzimidazolone carboxylic acid derivatives |
| 12/29/2005 | WO2005123717A1 7-pyrazolylbenzazepines having affinity for d3 receptor |
| 12/29/2005 | WO2005123716A1 Indole derivatives as histamine receptor antagonists |
| 12/29/2005 | WO2005123703A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 12/29/2005 | WO2005123697A1 Quinazoline derivatives |
| 12/29/2005 | WO2005123696A1 Substituted quinazolones as anti-cancer agents |
| 12/29/2005 | WO2005123691A1 Novel cis-imidazolines |
| 12/29/2005 | WO2005123688A2 3-aminoindazoles |
| 12/29/2005 | WO2005123672A2 Kinase inhibitors |
| 12/29/2005 | WO2005123671A1 Pyrrole derivative |
| 12/29/2005 | WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |